New findings demonstrate the clinical efficacy of AI-powered tissue analysis as a guide in cancer treatment, according to medical AI provider Lunit. The findings...
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced CE (ConformitéEuropéenne) Mark approval for SeekInClarityTM Cancer Treatment Response Monitoring Kit...
SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage determination was issued under the foundational policy "Melanoma Risk...
Vivera is pleased to announce the allowance of its third U.S. patent for ZICOH, the Company's high-tech, electronic dose-controlled portfolio of drug delivery devices....
